These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29528476)

  • 21. Erythro-austrobailignan-6 down-regulates HER2/EGFR/integrinβ3 expression via p38 activation in breast cancer.
    Han JH; Jeong HJ; Lee HN; Kwon YJ; Shin HM; Choi Y; Lee S; Oh ST; Kim DI; Jeon S
    Phytomedicine; 2017 Jan; 24():24-30. PubMed ID: 28160858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells.
    Rama AR; Prados J; Melguizo C; Burgos M; Alvarez PJ; Rodriguez-Serrano F; Ramos JL; Aranega A
    Biomed Pharmacother; 2011 Jul; 65(4):260-70. PubMed ID: 21723082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.
    De Iuliis F; Salerno G; Giuffrida A; Milana B; Taglieri L; Rubinacci G; Giantulli S; Terella F; Silvestri I; Scarpa S
    Tumour Biol; 2016 Feb; 37(2):2603-11. PubMed ID: 26392111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of expression of heat shock proteins and apoptosis by Flueggea leucopyrus (Willd) decoction in three breast cancer phenotypes.
    Mendis AS; Thabrew I; Samarakoon SR; Tennekoon KH
    BMC Complement Altern Med; 2015 Nov; 15():404. PubMed ID: 26553005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
    Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity.
    Shi X; Wang Y; Sun X; Wang C; Jiang P; Zhang Y; Huang Q; Liu X; Li D; Zhou J; Liu M
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/ Taxol) and explore its underlying mechanism].
    Liu Q; Liu XJ; Chen YJ; Wang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):326-30, 357. PubMed ID: 21826992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glaucarubulone glucoside from Castela macrophylla suppresses MCF-7 breast cancer cell growth and attenuates benzo[a]pyrene-mediated CYP1A gene induction.
    Badal SAM; Asuncion Valenzuela MM; Zylstra D; Huang G; Vendantam P; Francis S; Quitugua A; Amis LH; Davis W; Tzeng TJ; Jacobs H; Gangemi DJ; Raner G; Rowland L; Wooten J; Campbell P; Brantley E; Delgoda R
    J Appl Toxicol; 2017 Jul; 37(7):873-883. PubMed ID: 28138972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
    Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
    Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells.
    Luu TH; Bard JM; Carbonnelle D; Chaillou C; Huvelin JM; Bobin-Dubigeon C; Nazih H
    Cell Oncol (Dordr); 2018 Feb; 41(1):13-24. PubMed ID: 28993998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment of an aromatase inhibitor letrozole-resistant breast cancer cell model].
    Chen HY; Liu ZH
    Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):423-8. PubMed ID: 24119901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro.
    Thangapazham RL; Gaddipati JP; Rajeshkumar NV; Sharma A; Singh AK; Ives JA; Maheshwari RK; Jonas WB
    Integr Cancer Ther; 2006 Dec; 5(4):356-61. PubMed ID: 17101765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proliferative and cytotoxic activities of Allium autumnale P. H. Davis (Amaryllidaceae) on human breast cancer cell lines MCF-7 and MDA-MB-231.
    Isbilen O; Rizaner N; Volkan E
    BMC Complement Altern Med; 2018 Jan; 18(1):30. PubMed ID: 29370794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
    Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the effects of homeopathic Apis mellifica preparations on human gene expression profiles.
    Bigagli E; Luceri C; Bernardini S; Dei A; Filippini A; Dolara P
    Homeopathy; 2014 Apr; 103(2):127-32. PubMed ID: 24685417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
    Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
    Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
    Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
    BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
    Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
    Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential control of growth, cell cycle progression, and gene expression in human estrogen receptor positive MCF-7 breast cancer cells by extracts derived from polysaccharopeptide I'm-Yunity and Danshen and their combination.
    Hsieh TC; Wu JM
    Int J Oncol; 2006 Nov; 29(5):1215-22. PubMed ID: 17016654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.